Marker Therapeutics Inc (NASDAQ: MRKR) priced an underwritten public offering of 28.57 million common shares at $1.75 per share, representing a 31% discount from the last close price of $2.53 on ...

Russia’s flagship Urals crude is trading at its narrowest discount relative to benchmark prices since the Kremlin started its ...